Scientific Results Presented At ECCMID Demonstrate Well-
Differentiated Profile of Basilea's Two Phase III Anti- infective
BASEL, Switzerland, April 3, 2007 (PRIME NEWSWIRE) -- New data
presented at ECCMID
highlight the microbiological and
pharmacokinetic profiles of Basilea's (SWX:BSLN) two late-stage
drug candidates ceftobiprole and isavuconazole. Studies reported
both for ceftobiprole, the first anti-MRSA broad-spe...
Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki
...Microbiology and Infectious Diseases (ECCMID). The eccmid
taking place in Helsinki between 16t...antibiotic, is the subject of three
posters at the eccmid
conference. Novexel has recently completed a succe...//www.novexel.com ) shortly after the close of the eccmid
Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
...nisms in Staphylococcus aureus ; J. Locke, K. Shaw
Copies of these posters will be available on the Trius Web site following the eccmid
meeting: http://www.triusrx.com/posters.php .
About Trius Therapeutics
Trius Therapeutics is discovering and developing innovative ant...
AdvanDx Launches Fast, 90 Minutes Protocol for All CE-IVD Marked PNA FISH(R) Tests in Europe
Ther Clin Risk Manag. 2008 Jun;4(3):637-40
Antimicrob Agents Chemother. 2008 Oct;52(10):3558-63
Poster P1382. eccmid
2008, Barcelona, Spain
J Clin Microbiol. 2006 Sep;44(9):3381-3
AdvanDx Submits Yeast Traffic Light PNA FISH(TM) for FDA 510(k) Clearance for Detection of Candida species in Positive Blood Cultures
...ation of C. albicans and C. glabrata Directly from Blood Cultures using PNA FISH Technology on Selection of Antifungal Therapy. Poster 1382. eccmid
2008. Barcelona, Spain.
Arpida Provides Further Comments on the Pivotal Phase III Trials
... Extensive Data to be Presented at the Upcoming eccmid
REINACH, Switzerland, April 11 /PRNewswire-FirstCall/ -- Further to the
press release published on 9 April, Arpida Ltd. (SWX: ARPN) today...
Arpida Invited to Present Data on Iclaprim at Scientific Conference
...ed for the upcoming 18th European Congress of Clinical
Microbiology and Infectious Diseases (ECCMID) which takes place in
Barcelona, 19-22 April 2008. eccmid
is a premier European conference where
thousands of scientists and physicians gather to discuss the latest
developments in their field.
Arpida will ...